NDC 0378-6955

Bexarotene

Bexarotene

Bexarotene is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Bexarotene.

Product ID0378-6955_43459ab6-17fd-4c77-b269-4a97780af170
NDC0378-6955
Product TypeHuman Prescription Drug
Proprietary NameBexarotene
Generic NameBexarotene
Dosage FormCapsule, Liquid Filled
Route of AdministrationORAL
Marketing Start Date2015-07-09
Marketing CategoryANDA / ANDA
Application NumberANDA203174
Labeler NameMylan Pharmaceuticals Inc.
Substance NameBEXAROTENE
Active Ingredient Strength75 mg/1
Pharm ClassesRetinoid [EPC],Retinoids [CS]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0378-6955-01

100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0378-6955-01)
Marketing Start Date2015-07-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0378-6955-01 [00378695501]

Bexarotene CAPSULE, LIQUID FILLED
Marketing CategoryANDA
Application NumberANDA203174
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-07-09

Drug Details

Active Ingredients

IngredientStrength
BEXAROTENE75 mg/1

OpenFDA Data

SPL SET ID:2d1eb4bd-51f9-4c9b-9fb1-0be5e30a3dc5
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 308725
  • Pharmacological Class

    • Retinoid [EPC]
    • Retinoids [CS]
    • Retinoid [EPC]
    • Retinoids [CS]

    NDC Crossover Matching brand name "Bexarotene" or generic name "Bexarotene"

    NDCBrand NameGeneric Name
    0054-0399Bexarotenebexarotene
    0378-6955BexaroteneBexarotene
    0591-2832bexarotenebexarotene
    0832-0285BexaroteneBexarotene
    42292-007BexaroteneBexarotene
    43975-315BexaroteneBexarotene
    68682-002bexarotenebexarotene
    68682-003bexarotenebexarotene
    69238-1250BexaroteneBexarotene
    69238-2088BexaroteneBexarotene
    0187-5525Targretinbexarotene
    0187-5526Targretinbexarotene

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.